Works matching DE "RIFAXIMIN"

Results: 166

Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.

Published in:

Liver International, 2018, v. 38, n. 2, p. 295, doi. 10.1111/liv.13551

By:

García, Irma;
Gómez‐Hurtado, Isabel;
Gimenez, Paula;
González‐Navajas, José M.;
Bellot, Pablo;
Zapater, Pedro;
Francés, Rubén;
Manichanh, Chaysavanh;
Guarner, Francisco;
Ramos, José M.;
Such, José

Publication type:

Article

The Liver Meeting 2024: Bausch Health Presents Phase 3 Study Design for Investigational Rifaximin Formulation to Delay OHE.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Monotherapy with Rifaximin vs Lactulose More Effective for Reducing Recurrence of Overt Hepatic Encephalopathy: New Post Hoc Analysis.

Published in:

Patient Care (Online), 2024, p. 3

By:

Halsey, Grace

Publication type:

Article

Design and optimization of rifaximin macroparticles for colon targeting.

Published in:

Journal of Research in Pharmacy, 2024, v. 28, n. 5, p. 1609, doi. 10.29228/jrp.838

By:

CHATURVEDI, Ashwani K.;
SARA, UVS;
GUPTA, Ram Dayal

Publication type:

Article

Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1358, doi. 10.3390/jcm14041358

By:

Kawaratani, Hideto;
Namisaki, Tadashi;
Kondo, Yasuteru;
Tatsumi, Ryoji;
Kawabe, Naoto;
Tanabe, Norikazu;
Sakamaki, Akira;
Hoshikawa, Kyoko;
Uchida, Yoshihito;
Endo, Kei;
Kawaguchi, Takumi;
Oikawa, Tsunekazu;
Ishizu, Yoji;
Hige, Shuhei;
Takami, Taro;
Terai, Shuji;
Ueno, Yoshiyuki;
Mochida, Satoshi;
Koike, Kazuhiko;
Yoshiji, Hitoshi

Publication type:

Article

A Review of Pharmacologic and Non-Pharmacologic Therapies in the Management of Irritable Bowel Syndrome: Current Recommendations and Evidence.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 22, p. 6948, doi. 10.3390/jcm13226948

By:

Papale, Anthony J.;
Flattau, Robert;
Vithlani, Nandan;
Mahajan, Deepti;
Nadella, Sandeep

Publication type:

Article

The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 166, doi. 10.3390/jcm13010166

By:

Bellafante, Daniele;
Gioia, Stefania;
Faccioli, Jessica;
Riggio, Oliviero;
Ridola, Lorenzo;
Nardelli, Silvia

Publication type:

Article

Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade's Literature Focusing on Incidence, Risk Factors, and Prophylaxis.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 14, doi. 10.3390/jcm13010014

By:

Friis, Karina Holm;
Thomsen, Karen Louise;
Laleman, Wim;
Montagnese, Sara;
Vilstrup, Hendrik;
Lauridsen, Mette Munk

Publication type:

Article

Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 21, p. 6871, doi. 10.3390/jcm12216871

By:

Parisse, Simona;
Lai, Quirino;
Martini, Francesca;
Martini, Alice;
Ferri, Flaminia;
Mischitelli, Monica;
Melandro, Fabio;
Mennini, Gianluca;
Rossi, Massimo;
Alvaro, Domenico;
Ginanni Corradini, Stefano

Publication type:

Article

Rifaximin Use, Adherence and Persistence in Patients with Hepatic Encephalopathy: A Real-World Study in the South of Italy.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4515, doi. 10.3390/jcm12134515

By:

Pandico, Fulvio;
Citarella, Anna;
Cammarota, Simona;
Bernardi, Francesca Futura;
Claar, Ernesto;
Coppola, Carmine;
Cozzolino, Marianna;
De Rosa, Federica;
Di Gennaro, Massimo;
Fogliasecca, Marianna;
Giordana, Roberta;
Pacella, Daniela;
Russo, Alessandro;
Salerno, Vito;
Scafa, Luca;
Trama, Ugo

Publication type:

Article

Rifaximin Improves Liver Functional Reserve by Regulating Systemic Inflammation.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2210, doi. 10.3390/jcm12062210

By:

Kitsugi, Kensuke;
Kawata, Kazuhito;
Noritake, Hidenao;
Chida, Takeshi;
Ohta, Kazuyoshi;
Ito, Jun;
Takatori, Shingo;
Yamashita, Maho;
Hanaoka, Tomohiko;
Umemura, Masahiro;
Matsumoto, Moe;
Suda, Takafumi

Publication type:

Article

Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 934, doi. 10.3390/jcm12030934

By:

Bitto, Niccolò;
Ghigliazza, Gabriele;
Lavorato, Stanislao;
Caputo, Camilla;
La Mura, Vincenzo

Publication type:

Article

Effects of Rifaximin on Circulating Albumin Structures and Serum Ammonia Levels in Patients with Liver Cirrhosis: A Preliminary Study.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7318, doi. 10.3390/jcm11247318

By:

Miwa, Takao;
Hanai, Tatsunori;
Imai, Kenji;
Takai, Koji;
Shiraki, Makoto;
Hayashi, Hideki;
Shimizu, Shogo;
Nishigaki, Yoichi;
Tomita, Eiichi;
Shimizu, Masahito

Publication type:

Article

Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 7246, doi. 10.3390/jcm11237246

By:

Faccioli, Jessica;
Nardelli, Silvia;
Gioia, Stefania;
Riggio, Oliviero;
Ridola, Lorenzo

Publication type:

Article

Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1571, doi. 10.3390/jcm11061571

By:

Kawaratani, Hideto;
Kondo, Yasuteru;
Tatsumi, Ryoji;
Kawabe, Naoto;
Tanabe, Norikazu;
Sakamaki, Akira;
Okumoto, Kazuo;
Uchida, Yoshihito;
Endo, Kei;
Kawaguchi, Takumi;
Oikawa, Tsunekazu;
Ishizu, Yoji;
Hige, Shuhei;
Takami, Taro;
Terai, Shuji;
Ueno, Yoshiyuki;
Mochida, Satoshi;
Takikawa, Yasuhiro;
Torimura, Takuji;
Matsuura, Tomokazu

Publication type:

Article

Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment.

Published in:

Diseases, 2024, v. 12, n. 10, p. 260, doi. 10.3390/diseases12100260

By:

Castiglione, Roberto;
Bertino, Gaetano;
Vicari, Beatrice Ornella;
Rizzotto, Agostino;
Sidoti, Giuseppe;
D'Agati, Placido;
Salemi, Michele;
Malaguarnera, Giulia;
Vicari, Enzo

Publication type:

Article

Rifaximin in gut microbiota modification in acute pancreatitis: 15 years of retrospective clinical study.

Published in:

Advances in Clinical & Experimental Medicine, 2022, v. 31, n. 4, p. 399, doi. 10.17219/acem/144993

By:

Tatur, Jacek;
Lipiński, Michał;
Sznurkowska, Marta;
Józefik, Ewa;
Rydzewska, Grażyna

Publication type:

Article

Irritable bowel syndrome in adolescents.

Published in:

Journal of Alternative Medicine Research, 2023, v. 15, n. 4, p. 407

By:

Schmalz, Michael;
Gomes, Theotonius J.

Publication type:

Article

Study on the molecular mechanisms of rifaximin in the treatment of non‑alcoholic steatohepatitis based on the Helicobacter‑DCA‑Fxr‑Hnf1α signalling pathway.

Published in:

Molecular Medicine Reports, 2025, v. 31, n. 2, p. N.PAG, doi. 10.3892/mmr.2024.13407

By:

Wan, Yi-Peng;
Li, Shuang;
Li, Dan;
Huang, Xiao-Mei;
Wu, Jian-Hua;
Jian, Jie

Publication type:

Article

Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.

Published in:

PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0270786

By:

Nakai, Masato;
Suda, Goki;
Ogawa, Koji;
Yoshida, Sonoe;
Hosoda, Shunichi;
Kubo, Akinori;
Tokuchi, Yoshimasa;
Kitagataya, Takashi;
Yamada, Ren;
Shigesawa, Taku;
Ohara, Masatsugu;
Sho, Takuya;
Morikawa, Kenichi;
Sakamoto, Naoya

Publication type:

Article

Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis.

Published in:

PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0267647

By:

Fu, Jian;
Gao, Yi;
Shi, Li

Publication type:

Article

The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.

Published in:

PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264278

By:

Kimer, Nina;
Meldgaard, Mads;
Hamberg, Ole;
Kronborg, Thit Mynster;
Lund, Allan M.;
Møller, Holger Jon;
Bendtsen, Flemming;
Ytting, Henriette

Publication type:

Article

Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function.

Published in:

PLoS ONE, 2022, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0264459

By:

Yokoyama, Kunihiko;
Sakamaki, Akira;
Takahashi, Kazuya;
Naruse, Takumi;
Sato, Chihiro;
Kawata, Yuzo;
Tominaga, Kentaro;
Abe, Hiroyuki;
Sato, Hiroki;
Tsuchiya, Atsunori;
Kamimura, Kenya;
Takamura, Masaaki;
Yokoyama, Junji;
Terai, Shuji

Publication type:

Article

Development of a Simple and Sensitive HPLC Method for the Determination of Rifaximin in Serum and its Application.

Published in:

Indian Journal of Pharmaceutical Sciences, 2018, v. 80, n. 6, p. 1108, doi. 10.4172/pharmaceutical-sciences.1000462

By:

HOSSAIN, M. A.;
PERVIN, ROKEYA;
NA-HYE PARK;
KANG, J. W.;
LEE, K. J.;
SUH, J. W.;
PARK, S. C.

Publication type:

Article

Comparison of Safety and Efficacy of Neomycin versus Rifaximin in Chronic Recurrent Hepatic Encephalopathy.

Published in:

QJM: An International Journal of Medicine, 2024, v. 117, p. ii156, doi. 10.1093/qjmed/hcae175.363

By:

Ahmed Alaasar, Asmaa Ahmed Ali;
Monis, Ahmed Ali;
Riad, George Safwat;
Talkhan, Mohamed Gamal

Publication type:

Article

Gut Microbiota: a Perspective for Postpartum Depression.

Published in:

Gastrointestinal Nursing, 2023, v. 21, n. 4, p. 30, doi. 10.12968/gasn.2023.21.4.30

By:

Vadaei, Sima;
Milani, Payam Gonbari;
Soleimani, Roya Abedi;
Soleimani, Azar Abedi

Publication type:

Article

Rifaximin modulates TRH and TRH-like peptide expression throughout the brain and peripheral tissues of male rats.

Published in:

2022

By:

Pekary, Albert Eugene;
Sattin, Albert

Publication type:

journal article

On the Analytic Characteristics of Commercial Acetaminophen Assays in the United States .

Published in:

Journal of Applied Laboratory Medicine, 2022, v. 7, n. 6, p. 1311, doi. 10.1093/jalm/jfac059

By:

Ali, Khameinei;
Chiang, William;
Wang, Josh Jiaxing

Publication type:

Article

Rifaximin protects SH‐SY5Y neuronal cells from iron overload‐induced cytotoxicity via inhibiting STAT3/NF‐κB signaling.

Published in:

Cell Biology International, 2022, v. 46, n. 7, p. 1062, doi. 10.1002/cbin.11776

By:

Zhang, Zheng;
Yuan, Qi;
Hu, Xiaoxuan;
Liao, Jinmao;
Kuang, Jia

Publication type:

Article

Ziziphus spina-christi Leaf-Derived Carbon Dots as a Fluorescence Nanosensor to Evaluate Rifaximin Antibacterial via Inner Filter Effect: Greenness and Whiteness Studies.

Published in:

Chemosensors, 2023, v. 11, n. 5, p. 275, doi. 10.3390/chemosensors11050275

By:

Hamd, Mohamed A. El;
Albalawi, Marzough Aziz;
Gomaa, Hassanien;
Mohammad, Bassam Shaaban;
Abdul-Kareem, Rady F.;
Obaydo, Reem H.;
Alsaggaf, Wejdan T.;
Saleh, Safaa F.;
Alossaimi, Manal A.;
Abdel-Lateef, Mohamed A.

Publication type:

Article

Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation.

Published in:

Biomedicines, 2022, v. 10, n. 6, p. 1263, doi. 10.3390/biomedicines10061263

By:

Leone, Paola;
Mincheva, Gergana;
Balzano, Tiziano;
Malaguarnera, Michele;
Felipo, Vicente;
Llansola, Marta

Publication type:

Article

NiFe2O4/GO Nanocomposite as an Effective Adsorbent for Modelling Removal of Rifaximin from Pharmaceutical Wastewater Using Box–Behnken Response Surface Methodology.

Published in:

Russian Journal of General Chemistry, 2023, v. 93, p. S934, doi. 10.1134/S1070363223170103

By:

Malmir, M.;
Shemirani, F.

Publication type:

Article

Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model.

Published in:

Biomedical Reports, 2025, v. 22, n. 1, p. N.PAG, doi. 10.3892/br.2024.1882

By:

Longo, Larisse;
Guerreiro, Gabriel Tayguara Silveira;
Behrens, Luiza;
Pereira, Matheus Henrique Mariano;
Pinzon, Carlos Eduardo;
Cerski, Carlos Thadeu Schmidt;
Uribe-Cruz, Carolina;
Álvares-da-Silva, Mário Reis

Publication type:

Article

Post Marketing Observational Study of Fixed Dose Combination of Rifaximin and Metronidazole in The Management of Acute Diarrhea.

Published in:

Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy, 2023, v. 24, n. 2, p. 122, doi. 10.24871/2422023122-126

By:

Faruqui, Arif A.;
Shaikh, Shaguphta T.;
Ali, Faaria

Publication type:

Article

Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-69162-4

By:

Leite, Gabriela;
Rezaie, Ali;
Morales, Walter;
Weitsman, Stacy;
de Freitas Germano, Juliana;
Barlow, Gillian M.;
Parodi, Gonzalo;
Pimentel, Maya L.;
Villanueva-Millan, Maria Jesus;
Sanchez, Maritza;
Ayyad, Sarah;
Mathur, Ruchi;
Pimentel, Mark

Publication type:

Article

Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-69162-4

By:

Leite, Gabriela;
Rezaie, Ali;
Morales, Walter;
Weitsman, Stacy;
de Freitas Germano, Juliana;
Barlow, Gillian M.;
Parodi, Gonzalo;
Pimentel, Maya L.;
Villanueva-Millan, Maria Jesus;
Sanchez, Maritza;
Ayyad, Sarah;
Mathur, Ruchi;
Pimentel, Mark

Publication type:

Article

Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson's Disease: Preclinical and Clinical Studies.

Published in:

Cells (2073-4409), 2022, v. 11, n. 21, p. 3468, doi. 10.3390/cells11213468

By:

Hong, Chien-Tai;
Chan, Lung;
Chen, Kai-Yun;
Lee, Hsun-Hua;
Huang, Li-Kai;
Yang, Yu-Chen S. H.;
Liu, Yun-Ru;
Hu, Chaur-Jong

Publication type:

Article

Preparation of S-Scheme g-C 3 N 4 /ZnO Heterojunction Composite for Highly Efficient Photocatalytic Destruction of Refractory Organic Pollutant.

Published in:

Catalysts (2073-4344), 2023, v. 13, n. 3, p. 485, doi. 10.3390/catal13030485

By:

Sert, Buse;
Bilici, Zeynep;
Ocakoglu, Kasim;
Dizge, Nadir;
Rad, Tannaz Sadeghi;
Khataee, Alireza

Publication type:

Article

Review article: post‐TIPSS hepatic encephalopathy—current knowledge and future perspectives.

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 10, p. 1265, doi. 10.1111/apt.16825

By:

Gairing, Simon Johannes;
Müller, Lukas;
Kloeckner, Roman;
Galle, Peter R.;
Labenz, Christian

Publication type:

Article

Editorial: infections and hepatic encephalopathy–does the chicken or the egg come FIRST? A novel perspective at the horizon.

Published in:

2022

By:

Riggio, Oliviero;
Ridola, Lorenzo

Publication type:

Editorial

Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 4, p. 435, doi. 10.1111/apt.15326

By:

Salehi, Shayon;
Tranah, Thomas H.;
Lim, Samuel;
Heaton, Nigel;
Heneghan, Michael;
Aluvihare, Varuna;
Patel, Vishal C.;
Shawcross, Debbie L.

Publication type:

Article

Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1029, doi. 10.1111/apt.14361

By:

Goel, A.;
Rahim, U.;
Nguyen, L. H.;
Stave, C.;
Nguyen, M. H.

Publication type:

Article

A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin.

Published in:

Pharmaceutics, 2023, v. 15, n. 1, p. 126, doi. 10.3390/pharmaceutics15010126

By:

Zhuo, Xuezhi;
Margrethe Brekstad Kjellin, Maud;
Schaal, Zarah;
Zhang, Tengyu;
Löbmann, Korbinian;
Leng, Donglei

Publication type:

Article

Highly Polymorphic Materials and Dissolution Behaviour: The Peculiar Case of Rifaximin.

Published in:

Pharmaceutics, 2023, v. 15, n. 1, p. 53, doi. 10.3390/pharmaceutics15010053

By:

Bianchera, Annalisa;
Nebuloni, Marino;
Colombo, Nicola;
Pirola, Davide;
Bettini, Ruggero

Publication type:

Article

Effectiveness and Safety of Rifaximin-Containing Regimens for Helicobacter pylori Eradication: Systematic Review – Are They Potential Eradication Regimens?

Published in:

Infection & Drug Resistance, 2022, v. 15, p. 3733, doi. 10.2147/IDR.S371131

By:

Wang, Yu;
Tang, Jiong;
Zhou, Su;
Liang, Tian-Tian;
Wang, Fang-Fang;
Ning, Hong

Publication type:

Article

ANTIBIOTIC REFRACTORY POUCHITIS - CURRENT GUIDELINE TREATMENTS AND A NEED FOR CHANGE.

Published in:

Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, p. 82

By:

Roman, Adina;
Boeriu, Alina;
Matei, Andrada;
Dobru, Daniela

Publication type:

Article

Update on the Role of Rifaximin in Digestive Diseases.

Published in:

Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, n. 1, p. 92, doi. 10.15403/jgld-4871

By:

Dumitrascu, Dan;
Bakulin, Igor;
Berzigotti, Annalisa;
Cravo, Marília;
Gombošová, Laura;
Lukas, Milan;
Pietrzak, Anna;
María Remes-Troche, José;
Romero-Gómez1, Manuel;
Amieva Balmori, Mercedes;
Cúrdia Gonçalves, Tiago;
Hamzaoui, Lamine;
Juricek, Radovan;
Moreira, Leticia;
Neubauer, Katarzyna;
Surdea-Blaga, Teodora;
Tikhonov, Igor N.;
Trna, Jan;
Ianiro, Gianluca;
Ponziani, Francesca Romana

Publication type:

Article

Comparative Efficacy of Treatment Options for the Prevention of Post-TIPS Hepatic Encephalopathy: A Systematic Review and Network Meta-analysis.

Published in:

Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, n. 1, p. 70, doi. 10.15403/jgld-4508

By:

Ahmed, Zohaib;
Hassan, Mona;
Arif, Syeda Faiza;
Aziz, Muhammad;
Iqbal, Umair;
Nawaz, Ahmad;
Farooq, Umer;
Lee-Smith, Wade;
Badal, Joyce;
Renno, Anas;
Javaid, Toseef;
Nawras, Ali;
Saab, Sammy

Publication type:

Article

Rifaximin for the Management of Colonic Diverticular Disease: far Beyond a Simple Antibiotic.

Published in:

Journal of Gastrointestinal & Liver Diseases, 2018, v. 27, n. 4, p. 351, doi. 10.15403/jgld.2014.1121.274.rif

By:

Tursi, Antonio;
Scarpignato, Carmelo;
Brandimarte, Giovanni;
Di Mario, Francesco;
Lanas, Angel

Publication type:

Article

High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance.

Published in:

2025

By:

Lackner, Karl J.

Publication type:

Editorial